Francesco Ciccimarra
Bari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Myositis in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-017 systematic review and meta-analysis.
Journal: Expert opinion on drug safety
Published: August 13, 2026
Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study).
Journal: ESMO open
Published: April 21, 2026
Role of Local Treatment to the Prostate in Patients With de Novo Low-volume Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors.
Journal: European urology open science
Published: March 12, 2026
Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working group.
Journal: Expert opinion on pharmacotherapy
Published: February 04, 2026
Pharmacologic Features, Clinical Applications, and Drug Safety Evaluation of Inavolisib in the Treatment of Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: December 01, 2025
Bone metastases in advanced urothelial carcinoma patients receiving enfortumab vedotin: A Real-World study from the ARON-2EV project.
Journal: Clinical and experimental medicine
Published: November 25, 2025
Safety evaluation of TOPAZ-1 and KEYNOTE-966 regimens in metastatic biliary tract cancer: a systematic review and meta-analysis.
Journal: Clinical & experimental metastasis
Published: October 24, 2025
Hyponatremia in cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-014 meta-analysis.
Journal: Cancer metastasis reviews
Published: October 03, 2025
Prognostic value of systemic inflammatory markers in avelumab maintenance for advanced urothelial carcinoma: the multicentric SAILOR analysis.
Journal: Scientific reports
Published: July 21, 2025
Doublet Versus Triplet Therapy in High-volume Metastatic Hormone-sensitive Prostate Cancer Patients with Bone Metastases: Results from the ARON-3 Study.
Journal: European urology oncology
Published: July 07, 2025
Showing 1-11 of 11
Last Updated: 09/26/2026